Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
Merck
Argus Health
Moodys
US Department of Justice
Dow
Harvard Business School
UBS

Generated: November 17, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for N,N-Dimethyltryptamine

« Back to Dashboard

US Patents for N,N-Dimethyltryptamine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
N,N-Dimethyltryptamine ➤ Try a Free Trial Immunological methods for treating schizophrenia ➤ Try a Free Trial
N,N-Dimethyltryptamine ➤ Try a Free Trial Method for chemical promotion of the effects of low current transcranial electrostimulation ➤ Try a Free Trial
N,N-Dimethyltryptamine ➤ Try a Free Trial Method of inhibiting gastric acid secretion Eli Lilly and Company (Indianapolis, IN) ➤ Try a Free Trial
N,N-Dimethyltryptamine ➤ Try a Free Trial Method of inhibiting gastric acid secretion with benzodioxanes Eli Lilly and Company (Indianapolis, IN) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for N,N-Dimethyltryptamine

Drugname Country Document Number Estimated Expiration Related US Patent
N,N-Dimethyltryptamine Australia 6170990 2009-08-11 ➤ Try a Free Trial
N,N-Dimethyltryptamine Israel 95336 2009-08-11 ➤ Try a Free Trial
N,N-Dimethyltryptamine World Intellectual Property Organization (WIPO) 9101756 2009-08-11 ➤ Try a Free Trial
N,N-Dimethyltryptamine Austria 145553 2010-05-04 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Teva
US Department of Justice
Merck
Argus Health
Queensland Health
Daiichi Sankyo
Boehringer Ingelheim
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.